Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)
CNY 13.35
(0.3%)
CNY 13.35
(0.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 18.74 Million CNY | -95.37% |
| 2022 | 405.32 Million CNY | 115.7% |
| 2021 | 187.9 Million CNY | -12.82% |
| 2020 | 215.53 Million CNY | 13.6% |
| 2019 | 189.73 Million CNY | 68.57% |
| 2018 | 112.55 Million CNY | 76.2% |
| 2017 | 63.88 Million CNY | -35.12% |
| 2016 | 98.45 Million CNY | 7.6% |
| 2015 | 91.5 Million CNY | -0.11% |
| 2014 | 91.6 Million CNY | 8.02% |
| 2013 | 84.8 Million CNY | 12.79% |
| 2012 | 75.18 Million CNY | -18.44% |
| 2011 | 92.18 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 39.24 Million CNY | 591.1% |
| 2024 Q1 | 21.69 Million CNY | 156.35% |
| 2024 Q2 | 7.87 Million CNY | -63.69% |
| 2023 Q1 | 56.06 Million CNY | -57.31% |
| 2023 Q4 | -38.49 Million CNY | -265.65% |
| 2023 Q3 | 23.23 Million CNY | 205.33% |
| 2023 Q2 | -22.06 Million CNY | -139.35% |
| 2023 FY | 18.74 Million CNY | -95.37% |
| 2022 Q4 | 131.33 Million CNY | 206.26% |
| 2022 Q3 | 42.88 Million CNY | -57.6% |
| 2022 Q1 | 143.52 Million CNY | 655.78% |
| 2022 Q2 | 101.14 Million CNY | -29.53% |
| 2022 FY | 405.32 Million CNY | 115.7% |
| 2021 Q4 | 18.99 Million CNY | -12.97% |
| 2021 Q2 | 84.41 Million CNY | 34.67% |
| 2021 Q1 | 62.68 Million CNY | 94.14% |
| 2021 FY | 187.9 Million CNY | -12.82% |
| 2021 Q3 | 21.82 Million CNY | -74.15% |
| 2020 Q1 | 54.96 Million CNY | 184.55% |
| 2020 Q4 | 32.28 Million CNY | -28.59% |
| 2020 Q3 | 45.21 Million CNY | -45.58% |
| 2020 Q2 | 83.07 Million CNY | 51.14% |
| 2020 FY | 215.53 Million CNY | 13.6% |
| 2019 FY | 189.73 Million CNY | 68.57% |
| 2019 Q1 | 53.42 Million CNY | 78.03% |
| 2019 Q2 | 60.38 Million CNY | 13.02% |
| 2019 Q3 | 56.6 Million CNY | -6.25% |
| 2019 Q4 | 19.31 Million CNY | -65.88% |
| 2018 FY | 112.55 Million CNY | 76.2% |
| 2018 Q4 | 30 Million CNY | 1.94% |
| 2018 Q3 | 29.43 Million CNY | -31.82% |
| 2018 Q2 | 43.17 Million CNY | 334.85% |
| 2018 Q1 | 9.92 Million CNY | -51.1% |
| 2017 FY | 63.88 Million CNY | -35.12% |
| 2017 Q1 | 19.43 Million CNY | 24.0% |
| 2017 Q4 | 20.3 Million CNY | 543.66% |
| 2017 Q3 | 3.15 Million CNY | -84.97% |
| 2017 Q2 | 20.98 Million CNY | 7.97% |
| 2016 Q1 | 16.42 Million CNY | 0.0% |
| 2016 Q4 | 15.67 Million CNY | -38.46% |
| 2016 Q3 | 25.47 Million CNY | -37.7% |
| 2016 FY | 98.45 Million CNY | 7.6% |
| 2016 Q2 | 40.88 Million CNY | 148.96% |
| 2015 FY | 91.5 Million CNY | -0.11% |
| 2014 Q2 | 24.24 Million CNY | 0.0% |
| 2014 Q1 | 24.24 Million CNY | 0.0% |
| 2014 FY | 91.6 Million CNY | 8.02% |
| 2013 FY | 84.8 Million CNY | 12.79% |
| 2012 FY | 75.18 Million CNY | -18.44% |
| 2011 FY | 92.18 Million CNY | 0.0% |